| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |